1-Bromo-2-(chloromethyl)-4-iodobenzene

Catalog No.: 
ACXLGD427
CAS No.: 
946525-31-1
Molecular Formula: 
C7H5BrClI
Molecular Weight: 
331.38
1-Bromo-2-(chloromethyl)-4-iodobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$311.00InquiryInquiry
1g97%$950.00InquiryInquiry
5g97%$2915.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-2-(chloromethyl)-4-iodobenzene
IUPAC Name1-bromo-2-(chloromethyl)-4-iodobenzene
MDL No.MFCD18391676
Molecular FormulaC7H5BrClI
Molecular Weight331.38
SMILESIC1=CC=C(Br)C(CCl)=C1
InChI KeyIPTYFZLHONGTGW-UHFFFAOYSA-N
Synonym1-bromo-2-(chloromethyl)-4-iodobenzene;4-bromo-3-chloromethyl-1-iodo-benzene;Benzene, 1-bromo-2-(chloromethyl)-4-iodo-;2-Bromo-5-iodobenzyl chloride
CAS No.946525-31-1

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACXLGD427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWZU081 route compound structure diagram
    ACEWZU081946525-30-0In Stock
  4. Then
  5. ACXLGD427 route product structure diagram
    ACXLGD427946525-31-1
Inquiry

2. ACXLGD427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWZU081 route compound structure diagram
    ACEWZU081946525-30-0In Stock
  4. Then
  5. ACXLGD427 route product structure diagram
    ACXLGD427946525-31-1
Inquiry

3. ACXLGD427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLGD427 route product structure diagram
    ACXLGD427946525-31-1
Inquiry

Comments (0)